Davenport & CO LLC Moderna, Inc. Transaction History

Davenport & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$118.38 - $210.04 $176,859 - $313,799	1,494 New	1,494 $0
Q2 2022 Jul 18, 2022	SELL	$117.13 - $176.59 $3,045 - $4,591	-26 Reduced 1.44%	1,782 $255,000
Q1 2022 May 02, 2022	BUY	$126.46 - $235.05 $107,996 - $200,732	854 Added 89.52%	1,808 $311,000
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $418,218 - $682,480	-1,852 Reduced 66.0%	954 $242,000
Q3 2021 Oct 14, 2021	SELL	$221.9 - $484.47 $20,636 - $45,055	-93 Reduced 3.21%	2,806 $1.08 Million
Q2 2021 Jul 28, 2021	SELL	$129.91 - $234.98 $27,411 - $49,580	-211 Reduced 6.78%	2,899 $681,000
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $339,549 - $578,397	3,110 New	3,110 $407,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.